Reassessing the CLL prognostic index; ADAMTS13 conformation and risk of relapse in immune-mediated TTP; haploidentical bone marrow transplant in sickle cell disease
This episode covers the prognostic value of the CLL International Prognostic Index with targeted therapies, how peak ADAMTS13 activity relates to relapse risk in immune-mediated TTP, and findings from a phase 2 trial on haploidentical bone marrow transplant for sickle cell…